166 related articles for article (PubMed ID: 37142881)
1. Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study.
Hu Y; Zhu Y; Nie W; Shi J; Wei X; Tang C; Zhang W
Int J Clin Oncol; 2023 Jul; 28(7):880-892. PubMed ID: 37142881
[TBL] [Abstract][Full Text] [Related]
2. Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer.
Zhu Y; Hu Y; Shi J; Wei X; Song Y; Tang C; Zhang W
Technol Cancer Res Treat; 2023; 22():15330338231184995. PubMed ID: 37365925
[TBL] [Abstract][Full Text] [Related]
3. Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer.
Zhu Y; Hu Y; Zhu X; Zhang J; Yuwen D; Wei X; Tang C; Zhang W
Carcinogenesis; 2022 Sep; 43(8):736-745. PubMed ID: 35709525
[TBL] [Abstract][Full Text] [Related]
4. Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.
Peng W; Zhou Z; Zhong Y; Sun Y; Wang Y; Zhu Z; Jiao W; Bai M; Sun J; Lu J; Yin H
Sci Rep; 2019 Dec; 9(1):19084. PubMed ID: 31836775
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study.
Ye S; Chen X; Yao Y; Li Y; Sun R; Zeng H; Shu Y; Yin H
Sci Rep; 2019 Feb; 9(1):2652. PubMed ID: 30804354
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of thioredoxin reductase as a novel biomarker in liver cancer.
Wu X; Wang Q; Lu Y; Zhang J; Yin H; Yi Y
Sci Rep; 2021 Mar; 11(1):6069. PubMed ID: 33727662
[TBL] [Abstract][Full Text] [Related]
7. Plasma and Synovial Fluid TrxR Levels are Correlated With Disease Risk and Severity in Patients With Rheumatoid Arthritis.
Xie Z; Sun J; Li H; Shao T; Wang D; Zheng Q; Wen C
Medicine (Baltimore); 2016 Feb; 95(6):e2543. PubMed ID: 26871773
[TBL] [Abstract][Full Text] [Related]
8. Tissue and plasma thioredoxin reductase expressions in patients with glioblastoma multiforme.
Kemerdere R; Kacira T; Hanimoglu H; Kucur M; Tanriverdi T; Canbaz B
J Neurol Surg A Cent Eur Neurosurg; 2013 Jul; 74(4):234-8. PubMed ID: 23512591
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
[TBL] [Abstract][Full Text] [Related]
11. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
12. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
[TBL] [Abstract][Full Text] [Related]
13. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
14. Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms.
Zhang L; Cheng Q; Zhang L; Wang Y; Merrill GF; Ilani T; Fass D; Arnér ESJ; Zhang J
Free Radic Biol Med; 2016 Oct; 99():426-435. PubMed ID: 27581528
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma.
Kahlos K; Soini Y; Säily M; Koistinen P; Kakko S; Pääkkö P; Holmgren A; Kinnula VL
Int J Cancer; 2001 May; 95(3):198-204. PubMed ID: 11307155
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
[TBL] [Abstract][Full Text] [Related]
17. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.
Bellisola G; Fracasso G; Ippoliti R; Menestrina G; Rosén A; Soldà S; Udali S; Tomazzolli R; Tridente G; Colombatti M
Biochem Pharmacol; 2004 May; 67(9):1721-31. PubMed ID: 15081871
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma.
Li C; Peng Y; Mao B; Qian K
Oncotarget; 2015 Jul; 6(19):17792-804. PubMed ID: 25970775
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
Söderberg A; Sahaf B; Rosén A
Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
[TBL] [Abstract][Full Text] [Related]
20. Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.
Ren X; Zou L; Lu J; Holmgren A
Free Radic Biol Med; 2018 Nov; 127():238-247. PubMed ID: 29807162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
